Hongyan Liu
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Cardiovascular-Kidney Effects of Dapagliflozin in Patients at Cardiovascular Risk With or Without Type 2 Diabetes: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: December 05, 2025
Efficacy, Mechanisms, and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients: A Randomized, Double-Blind, Placebo-Controlled Trial.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: August 26, 2025
Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure.
Journal: Physiological reports
Published: January 15, 2025
Ketone production and excretion even during mild hyperglycemia and the impact of sodium-glucose co-transporter inhibition in type 1 diabetes.
Journal: Diabetes research and clinical practice
Published: October 11, 2023
SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis.
Journal: Current diabetes reports
Published: March 29, 2022
Associations Among Biomarkers of Inflammation, Tubular Injury and Lipid Metabolism With Gestational Diabetes Mellitus Status, Microalbuminuria and Retinopathy in the Microalbuminuria and Retinopathy in Gestational Diabetes Study.
Journal: Canadian journal of diabetes
Published: January 18, 2022
Renal hemodynamic dysfunction and neuropathy in longstanding type 1 diabetes: Results from the Canadian study of longevity in type 1 diabetes.
Journal: Journal of diabetes and its complications
Published: December 21, 2021
A Unique Multi- and Interdisciplinary Cardiology-Renal-Endocrine Clinic: A Description and Assessment of Outcomes.
Journal: Canadian journal of kidney health and disease
Published: November 01, 2021
In Reply to 'Finerenone: Fiddling With Hyperkalemia?'
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: August 03, 2021
Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease.
Journal: Metabolism: clinical and experimental
Published: July 29, 2021
Changes in plasma and urine metabolites associated with empagliflozin in patients with type 1 diabetes.
Journal: Diabetes, obesity & metabolism
Published: April 02, 2021
Markers of Kidney Injury, Inflammation, and Fibrosis Associated With Ertugliflozin in Patients With CKD and Diabetes.
Journal: Kidney international reports
Published: March 24, 2021
Last Updated: 09/26/2026